Start Date
April 1, 2023
Primary Completion Date
December 31, 2023
Study Completion Date
June 30, 2024
BioDFence G3
Placement of a sheet of BioDFence® G3 will be applied to the neurovascular bundle on participants undergoing an elective Full Nerve Sparing Radical Prostatectomy for primary treatment of prostate cancer.
AdventHealth, Celebration
Lead Sponsor
Collaborators (1)
Integra LifeSciences Corporation
INDUSTRY
AdventHealth
OTHER